Building Bridges: How Public-Private Collaboration Can Help Reshape Cardiovascular Innovation
Personalised cardiovascular medicine promises to give the right care to the right patient at the right time. But making that a reality takes more than a scientific breakthrough. It requires clinical expertise, patient data, technology, regulatory know-how and a path into everyday healthcare – expertise that rarely exists in one place. So how do we bring all the pieces together?
More Data, Better Care? The Promise and Reality of Digital Biomarkers in Cardiovascular Disease
We have more data on our hearts than ever before. Smartwatches track our rhythm around the clock. Implanted sensors monitor pressure and flow. Algorithms flag irregularities before symptoms appear. So why are we still diagnosing cardiovascular disease too late?
The Precision Moonshot: Redefining Cardiovascular Care for 85 Million Europeans
Cardiovascular disease affects 85 million Europeans, yet most patients are still treated as averages rather than individuals. In this article, our leading experts explore how personalised medicine could change that—transforming diagnosis, risk prediction, and treatment. They also unpack the barriers holding progress back, from fragmented data to outdated reimbursement models, and what it will take to bring truly patient-centred care into everyday practice.
The right treatment for the right patient: Rethinking heart failure care
Heart failure is a leading cause of hospitalisation in Europe, especially among older adults, and remains complex to treat, particularly alongside other conditions. Despite advances, outcomes still vary, pointing to the need for more tailored care. In this article, Prof. Hans-Peter Brunner-La Rocca explores what lies ahead for heart failure care.
“Suddenly, you are a patient 24 hours a day” – A patient perspective on living with heart failure
Heart failure affects millions worldwide, yet no two experiences are the same, shaping daily life in deeply personal ways. As care becomes more personalised, patient voices are increasingly vital. In this article, Max Groenhart shares his journey with heart failure and explains why involving patients in research is key to improving outcomes.
